{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T15:58:47Z","timestamp":1786636727615,"version":"build-2736575974"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Pharmacol"],"published-print":{"date-parts":[[2012]]},"DOI":"10.4103\/0253-7613.93840","type":"journal-article","created":{"date-parts":[[2012,3,14]],"date-time":"2012-03-14T13:58:06Z","timestamp":1331733486000},"page":"157","source":"Crossref","is-referenced-by-count":19,"title":["Renin angiotensin system: A novel target for migraine prophylaxis"],"prefix":"10.4103","volume":"44","author":[{"given":"Ruchika","family":"Nandha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harpal","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0253-7613.93840-1","first-page":"139","volume-title":"Involvement of the renin-angiotensin system in migraine","author":"Tronvik","year":"2006","journal-title":"J Hypertens"},{"key":"key-10.4103\/0253-7613.93840-2","first-page":"840","volume-title":"Pharmacological management of acute attacks of migraine and prevention of migraine headache","author":"Snow","year":"2002","journal-title":"Ann Intern Med"},{"key":"key-10.4103\/0253-7613.93840-3","first-page":"65","volume-title":"Prophylactic treatment of migraine with an angiotensin II receptor blocker: A randomized controlled trial","author":"Tronvik","year":"2003","journal-title":"JAMA"},{"key":"key-10.4103\/0253-7613.93840-4","first-page":"1","volume-title":"Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain","author":"Headache","year":"1988","journal-title":"Cephalalgia"},{"key":"key-10.4103\/0253-7613.93840-5","first-page":"72","volume-title":"Medications for migraine prophylaxis","author":"Modi","year":"2006","journal-title":"Am Fam Physician"},{"key":"key-10.4103\/0253-7613.93840-6","first-page":"S52","volume-title":"Current trends in migraine prophylaxis","author":"Ramadan","year":"2007","journal-title":"Headache"},{"key":"key-10.4103\/0253-7613.93840-7","first-page":"15","volume-title":"Recent advances in migraine preventive treatment on the basis of pathophysiological considerations","author":"Kumar","year":"2007","journal-title":"Trendz"},{"key":"key-10.4103\/0253-7613.93840-8","first-page":"41","volume-title":"Reduction in the therapeutic intensity of abortive migraine drug use during ACE inhibitor therapy-A pilot study","author":"Rahimtoola","year":"2004","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"key-10.4103\/0253-7613.93840-9","first-page":"S1","volume-title":"Conventional management and novel modalities for improved treatment of chronic migraine","author":"Lipton","year":"2009","journal-title":"Neurology"},{"key":"key-10.4103\/0253-7613.93840-10","first-page":"229","volume-title":"Enkephalinase inhibition relieves pain syndromes of central dysnociception (migraine and related headache)","author":"Sicuteri","year":"1981","journal-title":"Cephalalgia"},{"key":"key-10.4103\/0253-7613.93840-11","first-page":"193","volume-title":"Hypernociceptive syndromes and pharmacological inhibition of endogenous opioid degradation","author":"Baldi","year":"1986","journal-title":"Int J Clin Pharmacol Res"},{"key":"key-10.4103\/0253-7613.93840-12","first-page":"475","volume-title":"Captopril versus Placebo in the prevention of hemicranias without aura-A randomized double blind study","author":"Paterna","year":"1992","journal-title":"Clin Ter"},{"key":"key-10.4103\/0253-7613.93840-13","first-page":"2478","volume-title":"Angiotensin II AT 1 blockade normalizes cerebrovascular auto regulation and reduces cerebral ischemia in spontaneously hypertensive rats","author":"Nishimura","year":"2000","journal-title":"Stroke"},{"key":"key-10.4103\/0253-7613.93840-14","first-page":"17","volume-title":"Angiotensin receptors in the nervous system","author":"Allen","year":"1998","journal-title":"Brain Res Bull"},{"key":"key-10.4103\/0253-7613.93840-15","first-page":"328","volume-title":"Locally synthesized angiotensin modulates pineal melatonin generation","author":"Baltatu","year":"2002","journal-title":"J Neurochem"},{"key":"key-10.4103\/0253-7613.93840-16","first-page":"1266","volume-title":"Angiotensin II activates nuclear transcription factor \u03baB through AT 1 and AT 2 in vascular smooth muscle cells","author":"Ruiz-Ortega","year":"2000","journal-title":"Circ Res"},{"key":"key-10.4103\/0253-7613.93840-17","first-page":"507","volume-title":"Nuclear factor-kappaB as a molecular target for migraine therapy","author":"Reuter","year":"2002","journal-title":"Ann Neurol"},{"key":"key-10.4103\/0253-7613.93840-18","first-page":"235","volume-title":"Combined effects of ACE and MMP-3 polymorphisms on migraine development","author":"Kara","year":"2007","journal-title":"Cephalgia"},{"key":"key-10.4103\/0253-7613.93840-19","first-page":"133","volume-title":"Angiotensin-converting enzyme gene deletion polymorphism determines an increase in frequency of migraine attacks in patients suffering from migraine without aura","author":"Paterna","year":"2000","journal-title":"Eur Neurol"},{"key":"key-10.4103\/0253-7613.93840-20","first-page":"129","volume-title":"Association of the insertion\/deletion polymorphism of the angiotensin I-converting enzyme gene in patients of migraine with aura","author":"Kowa","year":"2005","journal-title":"Neuroscience"},{"key":"key-10.4103\/0253-7613.93840-21","first-page":"642","volume-title":"Efficacy of angiotensin II receptor antagonists in preventing headache systematic overview and meta-analysis","author":"Etminan","year":"2002","journal-title":"Am J Med"},{"key":"key-10.4103\/0253-7613.93840-22","first-page":"470","volume-title":"ACE inhibitors for prophylaxis of migraine headaches","author":"Bender","year":"1995","journal-title":"Headache"},{"key":"key-10.4103\/0253-7613.93840-23","first-page":"19","volume-title":"Prophylactic treatment of migraine with angiotensin converting enzyme inhibitor (lisinopril): Randomized, placebo controlled, crossover study","author":"Schrader","year":"2001","journal-title":"BMJ"},{"key":"key-10.4103\/0253-7613.93840-24","first-page":"441","volume-title":"Efficacy of candesartan in the treatment of migraine in hypertensive patients","author":"Owada","year":"2004","journal-title":"Hypertens Res"},{"key":"key-10.4103\/0253-7613.93840-25","first-page":"701","volume-title":"Efficacy of lisinopril in migraine prophylaxis\u202f-\u202fAn open label study","author":"Schuh-Hofer","year":"2007","journal-title":"Eur J Neurol"},{"key":"key-10.4103\/0253-7613.93840-26","first-page":"921","volume-title":"Telmisartan in migraine prophylaxis: A randomized, placebo-controlled trial","author":"Diener","year":"2009","journal-title":"Cephalalgia"}],"container-title":["Indian Journal of Pharmacology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T15:00:20Z","timestamp":1786633220000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0253-7613.93840"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012]]}},"alternative-id":["93840"],"URL":"https:\/\/doi.org\/10.4103\/0253-7613.93840","relation":{},"ISSN":["0253-7613"],"issn-type":[{"value":"0253-7613","type":"print"}],"subject":[],"published":{"date-parts":[[2012]]}}}